BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38226058)

  • 1. Liver organoids and their application in liver cancer research.
    Song X; Hou K; Zhou H; Yang J; Cao T; Zhang J
    Regen Ther; 2024 Mar; 25():128-137. PubMed ID: 38226058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor organoids: From inception to future in cancer research.
    Yang L; Yang S; Li X; Li B; Li Y; Zhang X; Ma Y; Peng X; Jin H; Fan Q; Wei S; Liu J; Li H
    Cancer Lett; 2019 Jul; 454():120-133. PubMed ID: 30981763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Organoids: Formation Strategies and Biomedical Applications.
    Zhu X; Zhang B; He Y; Bao J
    Tissue Eng Regen Med; 2021 Aug; 18(4):573-585. PubMed ID: 34132985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress and application of liver organoids in the study of liver cancer].
    Wang M; Xu ZY; Yu C; Zhang XY; Cao HY; Ma Y
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1332-1335. PubMed ID: 38253080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards manufacturing of human organoids.
    Ashok A; Choudhury D; Fang Y; Hunziker W
    Biotechnol Adv; 2020; 39():107460. PubMed ID: 31626951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the application of 3D tumor models in precision oncology and drug screening.
    Guan X; Huang S
    Front Bioeng Biotechnol; 2022; 10():1021966. PubMed ID: 36246388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
    Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
    Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of organoids in cancer research.
    Fang Z; Li P; Du F; Shang L; Li L
    Exp Hematol Oncol; 2023 Aug; 12(1):69. PubMed ID: 37537666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organoids of liver diseases: From bench to bedside.
    Wu LJ; Chen ZY; Wang Y; Zhao JG; Xie XZ; Chen G
    World J Gastroenterol; 2019 Apr; 25(16):1913-1927. PubMed ID: 31086460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-Functionalized Poly(ethylene glycol) Hydrogels as Scaffolds for Monolayer Organoid Culture.
    Wilson RL; Swaminathan G; Ettayebi K; Bomidi C; Zeng XL; Blutt SE; Estes MK; Grande-Allen KJ
    Tissue Eng Part C Methods; 2021 Jan; 27(1):12-23. PubMed ID: 33334213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organoids: The current status and biomedical applications.
    Yang S; Hu H; Kung H; Zou R; Dai Y; Hu Y; Wang T; Lv T; Yu J; Li F
    MedComm (2020); 2023 Jun; 4(3):e274. PubMed ID: 37215622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in organoids of the digestive system].
    Liu H; Wang R; Li X; Wu Z; Sun J; Lu W; Wang X
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1332-1350. PubMed ID: 37154309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
    Ren X; Chen W; Yang Q; Li X; Xu L
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and perspective of organoid technology in cancer-related translational medicine.
    Lin Y; Jiang L; He Q; Yuan M; Cao J
    Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancement of Organoid Technology in Regenerative Medicine.
    Arjmand B; Rabbani Z; Soveyzi F; Tayanloo-Beik A; Rezaei-Tavirani M; Biglar M; Adibi H; Larijani B
    Regen Eng Transl Med; 2023; 9(1):83-96. PubMed ID: 35968268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review).
    Cao J; Chan WC; Chow MSS
    Int J Oncol; 2022 May; 60(5):. PubMed ID: 35322860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal organoids: applications and future prospects.
    Liu H; Wang X
    J Mol Med (Berl); 2023 Aug; 101(8):931-945. PubMed ID: 37380866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges.
    Jabri A; Khan J; Taftafa B; Alsharif M; Mhannayeh A; Chinnappan R; Alzhrani A; Kazmi S; Mir MS; Alsaud AW; Yaqinuddin A; Assiri AM; AlKattan K; Vashist YK; Broering DC; Mir TA
    Bioengineering (Basel); 2024 Apr; 11(4):. PubMed ID: 38671768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
    Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
    OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.